http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1304120-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73b46a19d9635f31a98d8919333159f4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
filingDate 2001-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d26391497416f8c99bc80004955bc36
publicationDate 2003-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1304120-A1
titleOfInvention Use of oxaziridine derivatives and precursors for the treatment of dermatoses
abstract The present invention relates to the use of derivatives and their oxaziridine precursors (prodrugs) of formula I or II for the preparation of a medicament intended for the treatment or prevention of dermatoses.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107739741-A
priorityDate 2001-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129244222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468225393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15817734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511688

Total number of triples: 38.